Ars Technica
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
Independent advisors for the Food and Drug Administration on Friday voted 9–0 in support of approving Moderna's seasonal mRNA flu vaccine, which a Trump appointee at the agency initially tried to block from even being reviewed. In an…
View original source — Ars Technica ↗
Related stories
Straits Times
HealthJun 18, 2026 · 1 min
Moderna's mRNA flu vaccine backed by FDA advisers
Straits Times
The Hill
HealthJun 18, 2026 · 1 min
FDA panel recommends mRNA flu vaccine for older adults
The Hill
NPR
HealthJun 19, 2026 · 1 min
Key FDA committee unanimously recommends its first vaccine since 2023
NPR
The Hill
HealthJun 18, 2026 · 1 min
Senate Dems launch investigation into RFK Jr. vaccine panel changes
The Hill